top
Search terms
Results 1 - 10 of 16 - ordered by :
Pages: 1 2
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 08/03/2017 Item size : 424498 bytes
Ehjournal

Raising the level of high-density lipoprotein (HDL) cholesterol has been proposed as a potential therapeutic strategy to reduce cardiovascular risk, largely based on the epidemiological studies ...

European Heart Journal, Landmesser, Ulf, von Eckardstein, Arnold, Kastelein, John, Deanfield, John, Lüscher, Thomas F.

Date : 01/07/2012 Item size : 212974 bytes
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 09/03/2017
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Prevention is better that cure As Niccolo Machiavelli already pointed out in his seminal work Il Principe in 1513, any disease is ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/05/2015
Ehjournal

The metabolic syndrome not only precedes cardiovascular conditions, and hence represents an important cluster of risk factors,1,2 but also remains relevant in patients with established coronary ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/10/2015 Item size : 195267 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015
Ehjournal

MicroRNAs (miRNAs/miRs) emerge as promising sensitive and specific biomarkers for cardiovascular disease. [...]we sought to identify circulating miRNAs suitable for diagnosis of acute TTC and for ...

European Heart Journal, Jaguszewski, Milosz, Osipova, Julia, Ghadri, Jelena-Rima, Napp, Lars Christian, Widera, Christian, Franke, Jennifer, Fijalkowski, Marcin, Nowak, Radoslaw, Fijalkowska, Marta, ...

Date : 14/04/2014
Ehjournal

Statins are a cornerstone of cardiovascular prevention and are highly recommended in current guidelines.1 However, statin-associated muscle symptoms are one of the principal reasons for statin ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/05/2015 Item size : 141183 bytes
Ehjournal

Raising the level of high-density lipoprotein (HDL) cholesterol has been proposed as a potential therapeutic strategy to reduce cardiovascular risk, largely based on the epidemiological studies ...

European Heart Journal, Landmesser, Ulf, von Eckardstein, Arnold, Kastelein, John, Deanfield, John, Lüscher, Thomas F.

Date : 01/07/2012
Ehjournal

MicroRNAs (miRNAs/miRs) emerge as promising sensitive and specific biomarkers for cardiovascular disease. [...]we sought to identify circulating miRNAs suitable for diagnosis of acute TTC and for ...

European Heart Journal, Jaguszewski, Milosz, Osipova, Julia, Ghadri, Jelena-Rima, Napp, Lars Christian, Widera, Christian, Franke, Jennifer, Fijalkowski, Marcin, Nowak, Radoslaw, Fijalkowska, Marta, ...

Date : 14/04/2014